Adrian Treverton, Chief Executive Officer of Xstrahl, speaks about the types of patients who are the best candidates for radiation therapy.
Patients often prefer radiation therapy over surgery because it’s completely painless and non-invasive and there’s no scarring. With a 96% cure rate for the treatment of basal cell carcinoma, radiation therapy is a great option for many of these patients. In this video, Adrian Treverton, Chief Executive Officer of Xstrahl, speaks about the types of patients who are the best candidates for radiation therapy.
